Results 31 to 40 of about 1,092,122 (354)

Acute oxalate nephropathy: A potential cause of acute kidney injury in diabetes mellitus—A case series from a single center

open access: yesFrontiers in Medicine, 2022
BackgroundAcute oxalate nephropathy (AON) is an uncommon condition that causes acute kidney injury (AKI), characterized by the massive deposition of calcium oxalate crystals in the renal parenchyma. In previous studies, urinary oxalate excretion has been
Daorina Bao   +5 more
doaj   +1 more source

Renal Expression of Annexin A1 Is Associated With the Severity of Renal Injury in Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis

open access: yesFrontiers in Medicine, 2022
BackgroundIncreasing studies demonstrated the importance of activation of neutrophils in the pathogenesis of antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (AAV).
Rui-Xue Wang   +26 more
doaj   +1 more source

Biological Pathways and Potential Targets for Prevention and Therapy of Chronic Allograft Nephropathy [PDF]

open access: yes, 2014
Renal transplantation (RT) is the best option for patients with end-stage renal disease, but the half-life is limited to a decade due to progressive deterioration of renal function and transplant failure from chronic allograft nephropathy (CAN), which is
Haylor, John, Shrestha, Badri Man
core   +3 more sources

Effect of SGLT2 inhibitors on the proteinuria reduction in patients with IgA nephropathy

open access: yesFrontiers in Medicine, 2023
BackgroudRecent trials suggest sodium-glucose cotransporter 2 inhibitors (SGLT2i) significantly reduced proteinuria in patients with IgA nephropathy (IgAN).
Yaping Dong   +17 more
doaj   +1 more source

Questions about Chemokine and Chemokine Receptor Antagonism in Renal Inflammation [PDF]

open access: yes, 2010
Chemokines remain attractive therapeutic targets for modulating inflammatory diseases in all areas of medicine including acute and chronic kidney disease.
Anders, Hans-Joachim   +2 more
core   +1 more source

Reduction in Serum High-Sensitivity C-Reactive Protein Favors Kidney Outcomes in Patients with Impaired Fasting Glucose or Diabetes

open access: yesJournal of Diabetes Research, 2020
Objective. We aimed to evaluate whether the reduction in serum high-sensitivity C-reactive protein (hs-CRP) favors kidney outcomes. Methods. This study was a subanalysis including patients with impaired fasting glucose or diabetes of the Kailuan cohort ...
Lili Liu   +12 more
doaj   +1 more source

A modified renal risk score for Chinese patients with antineutrophil cytoplasmic antibody-associated vasculitis

open access: yesBMC Medicine, 2023
Background The renal risk score (RRS) is a useful tool to predict end-stage renal disease (ESRD) in patients with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV).
Rui-Xue Wang   +11 more
doaj   +1 more source

Progressive renal disease: Role of race and antihypertensive medications [PDF]

open access: yes, 1935
Progressive renal disease: Role of race and antihypertensive medications. Hypertension is associated with an accelerated rate of decline in renal function in patients with chronic renal disease. To identify factors that might alter the rate of decline in
Peter C. Brazy   +27 more
core   +1 more source

Renal function assessment in adults with recurrent calcium kidney stone disease [PDF]

open access: yes, 2012
The prevalence of nephrolihiasis and chronic kidney disease has risen over the past three decades, we sought to determine if person with a history of kidney stones have lower renal function relative to non stone formers.
Milladipour, Amir Hossein   +1 more
core   +1 more source

Benefit of Apabetalone on Plasma Proteins in Renal Disease. [PDF]

open access: yes, 2018
Introduction:Apabetalone, a small molecule inhibitor, targets epigenetic readers termed BET proteins that contribute to gene dysregulation in human disorders. Apabetalone has in vitro and in vivo anti-inflammatory and antiatherosclerotic properties.
Gilham, Dean   +11 more
core   +2 more sources

Home - About - Disclaimer - Privacy